Contraception

Contraception for women with mental illness

October 12, 2021

Women with mental illness who use contraception may have comparable or lower rates of mood symptoms with hormonal contraceptives than those who use other types of contraception, or no contraception at all.

Certain incentives may help those with OUD prevent unintended pregnancy

September 10, 2021

Among women with opioid use disorder (OUD) at high risk for unintended pregnancy, on-site contraceptive services coupled with financial incentives to attend follow-up visits to assess contraceptive satisfaction was a significantly more effective and cost-beneficial intervention than without incentives or with usual care, according to a prospective randomized clinical trial in JAMA Psychiatry.

Oral contraceptives and risk of cardiac events in women with congenital long-QT syndrome

August 18, 2021

Women with congenital long-QT syndrome (LQTS) have an increased risk of cardiac events, including sudden cardiac death, after the onset of adolescence, perhaps due to the effects of estrogen and progesterone on cardiac potassium channels.

Study finds risk of pregnancy low prior to IUD placement following recent unprotected sex

August 12, 2021

The findings of a secondary analysis from a randomized trial of intrauterine devices (IUDs) for emergency contraception should bolster confidence about the low pregnancy risk when providers insert an IUD following a recent episode of unprotected intercourse.

Oral contraceptive use during adolescence has small but meaningful link to future depression

July 29, 2021

Adolescent oral contraceptive use is associated with a small yet meaningful increased risk of experiencing an episode of major depressive disorder (MDD) in early adulthood, especially among women with no history of MDD in adolescence.

Contraceptive services, financial incentives may help those with OUD prevent unintended pregnancy

July 26, 2021

Among women with opioid use disorder (OUD) at high risk for unintended pregnancy, onsite contraceptive services coupled with financial incentives to attend follow-up visits to assess contraceptive satisfaction was a significantly more efficacious and cost-beneficial intervention than without incentives or with usual care, according to a prospective randomized clinical trial in JAMA Psychiatry.